Showing results (61-70 of 147) with videos related to
Sort By:
Pageof 15
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 27, 2015
Adjuvant carboplatin, paclitaxel, and vaginal cuff brachytherapy for stage III endometrial cancer: analysis of outcomes and patterns of recurrence based on pathologic characteristicsMelissa Rasar Young, Susan A Higgins, Elena Ratner, et al.Gynecologic Oncology|October 30, 2016
Platinum desensitization in patients with carboplatin hypersensitivity: A single-institution retrospective studyGary Altwerger, Gregory M Gressel, Diana P English, et al.Cancer|January 2, 2009
Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancerStefania Bellone, Simone Anfossi, Timothy J O'Brien, et al.American Journal of Obstetrics and Gynecology|November 4, 2008
Generation of CA125-specific cytotoxic T lymphocytes in human leukocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancerStefania Bellone, Simone Anfossi, Timothy J O'Brien, et al.American Journal of Obstetrics and Gynecology|September 6, 2011
Cervical carcinomas overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibodyJoyce Varughese, Emiliano Cocco, Stefania Bellone, et al.Cancer Prevention Research (Philadelphia, Pa.)|June 22, 2014
Flutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidenceChristine Gruessner, Angelika Gruessner, Katherine Glaser, et al.Gynecologic Oncology|October 22, 2011
A survey of gynecologic oncologists regarding the end-of-life discussion: a pilot studyKarim S El-Sahwi, Jessica Illuzzi, Joyce Varughese, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 22, 2014
Phase I clinical trial of the mammalian target of rapamycin inhibitor everolimus in combination with oral topotecan for recurrent and advanced endometrial cancerCarlos Acevedo-Gadea, Alessandro D Santin, Susan A Higgins, et al.Journal of Minimally Invasive Gynecology|February 7, 2026
Efficacy of laparoscopic-assisted transversus abdominus plane (LA-TAP) block for minimally invasive gynecologic surgeries (MIGS): A randomized controlled trialFarinaz Seifi, Jasmine W Jiang, Rachel White, et al.Gynecologic Oncology|November 1, 2011
Comparison between 155 cases of robotic vs. 150 cases of open surgical staging for endometrial cancerKarim S ElSahwi, Charlene Hooper, Maria C De Leon, et al.Pageof 15